TLC Vision announced today plans for a continued presence in Southern California, from Los Angeles to San Diego. The renewed commitment includes an agreement to maintain the long-standing relationship with Drs. Alan M. Berg and Robert E. Feinfield, whi…
Why "Honest Abe" Couldn’t Look You Straight In The Eye And Other Eyesight Challenges Of U.S. Presidents
We recognize the United States’ great presidents as visionaries, but have some of our leaders had trouble seeing – literally? This Presidents’ Day, EyeSmart™, the American Academy of Ophthalmology’s public awareness campaign empowering Americans to t…
Why "Honest Abe" Couldn’t Look You Straight In The Eye And Other Eyesight Challenges Of U.S. Presidents
We recognize the United States’ great presidents as visionaries, but have some of our leaders had trouble seeing – literally? This Presidents’ Day, EyeSmart™, the American Academy of Ophthalmology’s public awareness campaign empowering Americans to t…
In Treating A Leading Cause Of Childhood Blindness, Drug Therapy Shows Significant Benefit
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity. The results of a multicenter clinical trial led by res…
In Treating A Leading Cause Of Childhood Blindness, Drug Therapy Shows Significant Benefit
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity. The results of a multicenter clinical trial led by res…
Iris Pharma announces validation of new EIU model of ocular inflammation
Iris Pharma, a world leader CRO specialized in ophthalmology, today announced the validation of the Endotoxin-Induced Uveitis model, a new model of ocular inflammation.